Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Krishnendu Pal

Showing results (11-20 of 44) with videos related to

Pageof 5
Sort By:
Molecular Cancer Therapeutics|October 22, 2016
Mutant BRAF Upregulates MCL-1 to Confer Apoptosis Resistance that Is Reversed by MCL-1 Antagonism and Cobimetinib in Colorectal CancerHisato Kawakami, Shengbing Huang, Krishnendu Pal, et al.
NPJ Precision Oncology|December 17, 2019
Synchronous inhibition of mTOR and VEGF/NRP1 axis impedes tumor growth and metastasis in renal cancerKrishnendu Pal, Vijay Sagar Madamsetty, Shamit Kumar Dutta, et al.
Pharmaceutics|October 29, 2025
Lipid Nanoparticle-Mediated RNAi Against GIPC1 Overcomes Chemoresistance in Pancreatic Ductal AdenocarcinomaVijay Sagar Madamsetty, Hari Krishnareddy Rachamala, Shamit Kumar Dutta, et al.
BMC Cancer|May 28, 2016
Selective mode of action of plumbagin through BRCA1 deficient breast cancer stem cellsVeena Somasundaram, Sreelatha K Hemalatha, Krishnendu Pal, et al.
Cancer Research|June 14, 2012
VEGF exerts an angiogenesis-independent function in cancer cells to promote their malignant progressionYing Cao, Guangqi E, Enfeng Wang, et al.
Journal of Translational Medicine|December 3, 2025
Strategic trimodal therapy enhances radiation-induced abscopal response in renal cancerHari Krishnareddy Rachamala, Naga Malleswara Rao Nakka, Shamit Kumar Dutta, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 19, 2009
Selective cancer targeting via aberrant behavior of cancer cell-associated glucocorticoid receptorAmarnath Mukherjee, Kumar P Narayan, Krishnendu Pal, et al.
Frontiers in Oncology|September 8, 2022
Expression, correlation, and prognostic significance of different nicotinic acetylcholine receptors, programed death ligand 1, and dopamine receptor D2 in lung adenocarcinomaKrishnendu Pal, Tabish Hussain, Hao Xie, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine|March 9, 2019
Tumor selective uptake of drug-nanodiamond complexes improves therapeutic outcome in pancreatic cancerVijay S Madamsetty, Anil Sharma, Maria Toma, et al.
Nanoscale|November 12, 2019
Development of multi-drug loaded PEGylated nanodiamonds to inhibit tumor growth and metastasis in genetically engineered mouse models of pancreatic cancerVijay Sagar Madamsetty, Krishnendu Pal, Sandeep Keshavan, et al.
Pageof 5

Showing results (11-20 of 44) with videos related to

Sort By:
Pageof 5
Molecular Cancer Therapeutics|October 22, 2016
Mutant BRAF Upregulates MCL-1 to Confer Apoptosis Resistance that Is Reversed by MCL-1 Antagonism and Cobimetinib in Colorectal CancerHisato Kawakami, Shengbing Huang, Krishnendu Pal, et al.
NPJ Precision Oncology|December 17, 2019
Synchronous inhibition of mTOR and VEGF/NRP1 axis impedes tumor growth and metastasis in renal cancerKrishnendu Pal, Vijay Sagar Madamsetty, Shamit Kumar Dutta, et al.
Pharmaceutics|October 29, 2025
Lipid Nanoparticle-Mediated RNAi Against GIPC1 Overcomes Chemoresistance in Pancreatic Ductal AdenocarcinomaVijay Sagar Madamsetty, Hari Krishnareddy Rachamala, Shamit Kumar Dutta, et al.
BMC Cancer|May 28, 2016
Selective mode of action of plumbagin through BRCA1 deficient breast cancer stem cellsVeena Somasundaram, Sreelatha K Hemalatha, Krishnendu Pal, et al.
Cancer Research|June 14, 2012
VEGF exerts an angiogenesis-independent function in cancer cells to promote their malignant progressionYing Cao, Guangqi E, Enfeng Wang, et al.
Journal of Translational Medicine|December 3, 2025
Strategic trimodal therapy enhances radiation-induced abscopal response in renal cancerHari Krishnareddy Rachamala, Naga Malleswara Rao Nakka, Shamit Kumar Dutta, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 19, 2009
Selective cancer targeting via aberrant behavior of cancer cell-associated glucocorticoid receptorAmarnath Mukherjee, Kumar P Narayan, Krishnendu Pal, et al.
Frontiers in Oncology|September 8, 2022
Expression, correlation, and prognostic significance of different nicotinic acetylcholine receptors, programed death ligand 1, and dopamine receptor D2 in lung adenocarcinomaKrishnendu Pal, Tabish Hussain, Hao Xie, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine|March 9, 2019
Tumor selective uptake of drug-nanodiamond complexes improves therapeutic outcome in pancreatic cancerVijay S Madamsetty, Anil Sharma, Maria Toma, et al.
Nanoscale|November 12, 2019
Development of multi-drug loaded PEGylated nanodiamonds to inhibit tumor growth and metastasis in genetically engineered mouse models of pancreatic cancerVijay Sagar Madamsetty, Krishnendu Pal, Sandeep Keshavan, et al.
Pageof 5